tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Precision BioSciences reports safety, efficacy data for ELIMINATE-B trial cohort
PremiumThe FlyPrecision BioSciences reports safety, efficacy data for ELIMINATE-B trial cohort
1M ago
Precision BioSciences Reports Promising Phase 1 Trial Results
Premium
Company Announcements
Precision BioSciences Reports Promising Phase 1 Trial Results
1M ago
Precision BioSciences granted Orphan Drug Designation for PBGENE-DMD
Premium
The Fly
Precision BioSciences granted Orphan Drug Designation for PBGENE-DMD
2M ago
Precision BioSciences: Promising Gene Editing Platform Targets Chronic HBV and DMD with Strategic Focus
PremiumRatingsPrecision BioSciences: Promising Gene Editing Platform Targets Chronic HBV and DMD with Strategic Focus
3M ago
Precision BioSciences Holds Annual Stockholder Meeting
Premium
Company Announcements
Precision BioSciences Holds Annual Stockholder Meeting
3M ago
Buy Rating for Precision BioSciences: Promising ARCUS-Based Programs and Strong Gene Editing Prospects
Premium
Ratings
Buy Rating for Precision BioSciences: Promising ARCUS-Based Programs and Strong Gene Editing Prospects
4M ago
Precision BioSciences reports Q1 EPS ($2.21), consensus ($2.42)
PremiumThe FlyPrecision BioSciences reports Q1 EPS ($2.21), consensus ($2.42)
4M ago
Precision BioSciences Accelerates PBGENE-DMD Program for DMD
Premium
Company Announcements
Precision BioSciences Accelerates PBGENE-DMD Program for DMD
4M ago
Optimistic Buy Rating for Precision BioSciences Driven by Promising Safety Data and Potential Functional Cure for HBV
Premium
Ratings
Optimistic Buy Rating for Precision BioSciences Driven by Promising Safety Data and Potential Functional Cure for HBV
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100